Galmed Pharmaceuticals Ltd. (GLMD) CEO Allen Baharaff on Q1 2021 Results - Earnings Call Transcript

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Q1 2021 Earnings Conference Call May 13, 2021 8:30 AM ET

Company Participants

Allen Baharaff - President & Chief Executive Officer
Liat Hayardeny - Chief Scientific Officer
Yohai Stenzler - Chief Financial Officer

Conference Call Participants

Steve Seedhouse - Raymond James
Thomas - H.C. Wainwright
Rick - Cantor Fitzgerald

Operator

Good day. Welcome to the Galmed Conference Call to discuss Financial Results for the First Quarter 2021. Today's conference is being recorded.

Before we begin, please note that we'll be making certain forward-looking statements on today's call, including those regarding financial results, statements and forecasts regarding anticipated timelines and expectations with respect to our regulatory and clinical development programs as well as other statements that relate to future events.

These statements are based on the beliefs and expectations of management as of today and actual results, trends, timelines, and projections relating to our financial position and projected development programs and pipeline could differ materially.

We urge all investors to read carefully the risks and uncertainties disclosed in our filings with the SEC, including without limitation, the risks under the heading, Risk Factors described in our Annual Report on Form 20-F filed with the SEC. Galmed assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates only.

I would now like to turn the call over to Allen Baharaff, President and Chief Executive Officer. Allen, please go ahead.

Allen Baharaff

Thank you [ph]Dona. Good morning and thank you for joining us on today's conference call. I'm pleased to be here today with our Chief Scientific Officer, Dr. Liat Hayardeny; and our Chief Financial Officer, Yohai Stenzler, to provide you with an update on our clinical development programs as well as we report to you on our financial results for the first quarter of 2021. As always, we would be happy